Geron Corp
NASDAQ:GERN
Geron Corp
NASDAQ:GERN
Price:
1.56
USD
-0.64%
Market Cap:
$999.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Geron Corp
NASDAQ:GERN
|
US |
|
Generative AI Solutions Corp
OTC:AICOF
|
CA |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
B
|
Blue Sky Energy Inc
XTSX:BSI.H
|
CA |
|
Ariston Holding NV
MIL:ARIS
|
IT |
|
Nan Ya Printed Circuit Board Corp
TWSE:8046
|
TW |
|
R
|
Rusta AB (publ)
STO:RUSTA
|
SE |
|
NFI Group Inc
TSX:NFI
|
CA |
|
Target Hospitality Corp
NASDAQ:TH
|
US |
|
L
|
Leaddesk Oyj
OMXH:LEADD
|
FI |
|
H
|
Healthlead PCL
SET:HL
|
TH |
|
Chaarat Gold Holdings Ltd
LSE:CGH
|
VG |
|
S
|
Stark Corporation PCL
SET:STARK
|
TH |
Multiples-Based Value
The Multiples-Based Value of one
GERN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.56 USD,
Geron Corp
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GERN Multiples-Based Value
LOCKED
Multiples Across Competitors
GERN Competitors Multiples
Geron Corp Competitors
Geron Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Geron Corp
NASDAQ:GERN
|
1B USD | 5.4 | -12 | -17 | -16.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6.1 | 89.1 | 14.8 | 20.5 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD | 109.7 | -1 713.1 | 15 914.4 | -1 797 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.2 | 24.6 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.6 | 29.1 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.6 | 17.8 | 13.2 | 15.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.2 | 35.2 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
